Artelo Biosciences (NASDAQ:ARTL) just reported results for the first quarter of 2024.
- Artelo Biosciences reported earnings per share of -78 cents. This was above the analyst estimate for EPS of -$1.05.
- The company did not report any revenue for the quarter.